| Megan E Weiss, LPC | |
|
1655 W Mequon Rd, Mequon, WI 53092-3254 | |
| (414) 607-5280 | |
| Not Available |
| Full Name | Megan E Weiss |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1655 W Mequon Rd, Mequon, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174014641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 10825-125 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan E Weiss, LPC 1655 W Mequon Rd, Mequon, WI 53092-3254 Ph: (414) 322-5808 | Megan E Weiss, LPC 1655 W Mequon Rd, Mequon, WI 53092-3254 Ph: (414) 607-5280 |
News Archive
Controlling neglected tropical diseases (NTDs) in developing countries would help improve the reproductive health and rights of girls and women in the poorest countries of Africa, Asia, Latin America, and the Caribbean, according to a new editorial published November 24 in the open-access journal PLoS Neglected Tropical Diseases.
Researchers at Temple University School of Medicine have been awarded a $7.4 million, five-year grant from the National Institute on Drug Abuse to determine how cocaine and HIV-1 interact to cause brain impairment in patients infected with the human immunodeficiency virus.
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
The first study of its kind evaluating ordering patterns of children's meals when provided with healthier menu items and changes in restaurant revenues shows potential for both improved children's health and restaurant growth.
The issuer's China based operating subsidiary Mellow Hope through its exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd has been granted H1N1 license on September 24, 2009 by SFDA (China Authority) http://eng.sfda.gov.cn/eng. Mellow Hope is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales.
› Verified 6 days ago
Lauren Griffith, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 11518 N Port Washington Rd Ste 202, Mequon, WI 53092 Phone: 262-244-6177 | |
Alyssa Nicole Eckman, MS, LPC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1655 W Mequon Rd, Mequon, WI 53092 Phone: 414-292-4242 Fax: 262-240-9745 | |
Gary M Gallitz, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10500 N Port Washington Rd, Mequon, WI 53092 Phone: 262-240-0427 Fax: 262-240-0429 | |
Dawn Cataldo, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14135 N Cedarburg Rd Ste 205, Mequon, WI 53097 Phone: 414-662-4149 | |
Mr. Jason Stuart Kantrowitz, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 10042 N. Brookdale Dr., Mequon, WI 53092 Phone: 414-534-2979 Fax: 262-292-8184 | |
Mr. Corey F Garber, LPC, SAC-T Counselor Medicare: Not Enrolled in Medicare Practice Location: 10532 N. Port Washington Rd., Suite 1b, Mequon, WI 53092 Phone: 262-242-3810 Fax: 262-242-3816 | |
Ms. Stacey Lynn Yonkoski, MSW, LCSW, CADCIII Counselor Medicare: Not Enrolled in Medicare Practice Location: 1500 W Market St, Suite 200, Mequon, WI 53092 Phone: 262-241-6127 |